A Pilot Study

Absorption, Safety, and Detoxification Effects of Oral Liposomal Glutathione

Abstract

Abstract

A pilot clinical study was undertaken to assess the effect of liposomal glutathione on blood levels and detoxification processes (N=2). Peak

Seven other healthy individuals took 750 mg of liposomal glutathione (CELLg8®) twice daily for 30 days. Improved detoxification and liver function was demonstrated by decreased bilirubin and 39% decreased blood mercury.  All other indicators of the 21 blood panel remained healthy during the 30 days without any significant change. 

Further testing is in processes to extend the study by an N of 12.

A pilot clinical study was undertaken to assess the effect of liposomal glutathione on glutathione blood levels after 2 hours (N=4).

Seven other healthy individuals took 750 mg of liposomal glutathione (CELLg8®) twice daily for 30 days. Improved detoxification and liver function was demonstrated by decreased bilirubin and 39% decreased blood mercury. All other indicators of the 21 blood panel remained healthy during the 30 days without any significant change other than a positive change for kidney and liver function.

Further testing is in processes to extend the study by an N of 12.